Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dimerizer-regulated gene expression.

Roy Pollock1, Tim Clackson

  • 1ARIAD Gene Therapeutics, 26 Landsdowne Street, Cambridge, MA 02139, USA. roy.pollock@ariad.com

Current Opinion in Biotechnology
|December 3, 2002
PubMed
Summary

Small molecules control gene expression for research and gene therapy. Chemical inducers of dimerization (dimerizers) offer precise regulation and modularity, with new dimerizers and clinical applications emerging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.

Journal for immunotherapy of cancer·2024
Same author

Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancer.

Bioorganic & medicinal chemistry letters·2022
Same author

Mobocertinib (TAK-788): A Targeted Inhibitor of <i>EGFR</i> Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer.

Cancer discovery·2021
Same author

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2018
Same author

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.

Blood·2018
Same author

The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models.

Clinical cancer research : an official journal of the American Association for Cancer Research·2016

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Chemical Biology

Background:

  • Small molecules offer precise control over gene expression, a critical tool in biological research and a key component of advanced gene therapy strategies.
  • Chemical inducers of dimerization (dimerizers) provide a modular and tightly regulated method for controlling gene expression, minimizing potential immune responses by utilizing human proteins.
  • Existing rapamycin-based systems demonstrate the potential of dimerizers, paving the way for new therapeutic applications.

Purpose of the Study:

  • To explore the advantages and recent developments in using chemical inducers of dimerization for controlling gene expression.
  • To highlight the clinical utility of dimerizer systems in regulated gene therapy.
  • To review progress in developing novel dimerizers and their application in gene therapy vectors.

Main Methods:

  • Utilizing small molecules as chemical inducers of dimerization to regulate gene expression.
  • Developing and testing new chemical dimerizers based on existing drugs like FK506, dexamethasone, and methotrexate.
  • Investigating the use of adeno-associated virus and adenovirus vectors for gene therapy applications regulated by dimerizer systems.

Main Results:

  • Demonstrated the advantages of dimerizers, including tight regulation and modularity for iterative improvements.
  • Reported the development of novel chemical dimerizers beyond rapamycin analogs.
  • Showcased progress in the clinical application of gene therapy vectors controlled by dimerizer systems.

Conclusions:

  • Chemical inducers of dimerization represent a powerful and versatile tool for controlling gene expression in both research and clinical settings.
  • The development of new dimerizers and their integration with gene therapy vectors are advancing the field of regulated gene therapy.
  • Dimerizer technology holds significant promise for precise and safe therapeutic gene modulation.

Related Experiment Videos